604 Views | 502 Downloads
Address correspondence to: Shoichiro Ono (sono@emory.edu).
We thank Ronen Zaidel-Bar and Jeff Hardin for communicating their preliminary results on aipl-1 RNAi. Monoclonal antibody 5–6 was developed by Henry Epstein (University of Texas Medical Branch, Galveston, TX) and was obtained from the Developmental Studies Hybridoma Bank developed under auspices of the National Institute of Child Health and Human Development and maintained by the Department of Biological Sciences, University of Iowa, Iowa City, IA. Some C. elegans strains were provided by the Caenorhabditis Genetics Center, which is supported by the National Institutes of Health National Center for Research Resources.
This work was supported by grants from the Natural Sciences and Engineering Research Council of Canada to D.L.B. and the National Institutes of Health (R01 AR48615) and University Research Committee of Emory University to S.O.
© 2011 Ono et al. This article is distributed by The American Society for Cell Biology under license from the author(s). Two months after publication it is available to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).